https://www.selleckchem.com/pr....oducts/epacadostat-i
Age≥70 years (OR 3.20, 95%CI 1.09-9.41, p=0.035) was an independent predictor of undertreatment. Patients with longer-known PDAC (≥30 days) showed improved pain management compared to new cases (OR 0.19, 95%CI 0.05-0.81, p=0.025). Treatment by gastroenterologists (OR 0.22, 95%CI 0.05-0.89, p=0.034) was associated with less undertreatment. The results show a high proportion of PDAC patients with pain, pain interference and undertreatment, whose characteristics could help to identify patients at risk in the future. Several
Like
Comment
Share
